Table 2 Characteristics of devices (N = 215)
N (%) | Median (IQR) | |
|---|---|---|
Number of devices/patient | 2 (2) | |
Indwelling time (hours) | 72 (48) | |
Site of PVC insertion | ||
Dorsum of the hand | 170 (78.8) | |
Wrist | 2 (1) | |
Antecubital fossa | 3 (1.5) | |
Lower arm | 2 (1) | |
Foot | 37 (17.2) | |
Head | 1 (0.5) | |
Cannula gauge | ||
22G (blue) | 115 (53.5) | |
24 G (yellow) | 100 (46.5) | |
Reason for PVC insertion | ||
Infusion | 145 (67.4) | |
Medication | 53 (24.7) | |
Blood product transfusion | 17 (7.9) | |
Administration method | ||
Gravitational | 114 (53) | |
Volume-controlled burette | 53 (24.7) | |
Infusion pump | 48 (22.3) | |
Fluids | 58 (27) | |
5% Dextrose | 28 (13) | |
10% Dextrose | 21 (9.8) | |
Normosaline solution | 9 (4.2) | |
Drugs (one or more)/device | 145 (67.4) | |
Number of drugs/device | ||
Antibiotics (one or more)/device | 114 (53) | 1 (1) |
Aciclovir | 7 (3.3) | |
Paracetamol | 31 (14.4) | |
Corticosteroids | 16 (7.4) | |
Proton Pump Inhibitors | 26 (12.1) | |
Pamidronate | 7 (3.2) | |
Other | 11 (5.1) | |
Rhythm of device use/day (N = 165) | ||
≤3 times | 92 (42.8) | |
> 3 times | 123 (57.2) | |